Hold Big Pharma Accountable!
Hold Big Pharma Accountable for their Vaccines! End Legal Indemnity for Vaccine Manufacturers
Hold Big Pharma Accountable for their Vaccines! End Legal Indemnity for Vaccine Manufacturers
Big Pharma has been protected by the Federal Government for far too long.
Many Australian families have reported incidents of serious ‘vacccine’ injury as a result of the experimental COVID-19 shots. And yet, because of a sweetheart deal with the Federal Government, vaccine manufacturers are untouchable.
How so?
Well, they have legal indemnity, which means that Big Pharma companies, who have made a fortune off the experimental COVID-19 vaccines, can't be taken to court, even when Australians suffer severe adverse effects. If you or a loved one has been harmed, you're out of luck, with no legal recourse.
But now, we have a window of opportunity to make things right.
A bill has been introduced into the Parliament by Senator Ralph Babet that will remove legal indemnity for vaccine manufacturers.
That bill – the Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 – is currently subject to a Senate inquiry. Submissions to that inquiry are being taken by the Senate Standing Committees on Finance and Public Administration until 29 September 2023.
The arguments in favour of passing this bill are overwhelming.
It's about accountability and safety. Without having to worry about legal repercussions, vaccine manufacturers aren't incentivised to maintain the highest safety standards.
It's about trust and transparency. When people know that manufacturers can be held responsible, they can trust the product more.
It's also about consumer rights. Without indemnity protections, manufacturers will be less inclined to rush products to the market without thorough testing. This could lead to better market competition and higher safety profiles. Legal challenges can lead to a greater understanding of potential vaccine side effects.
Moreover, holding manufacturers financially responsible ensures that costs associated with potential side effects aren't borne solely by individuals or the public healthcare system.
Removing indemnity would align the vaccine industry with others, where product liability is a key component of doing business.
If enough members of the public inform the Senate Standing Committees on Finance and Public Administration inquiry that they wish for the Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 to be passed, then the committee may recommend the Senate pass the bill.
We're at a crossroads. Without action, the Senate might reject the bill, leaving us where we started: powerless.
But with your help, we can win this fight.
The Senate could pass the bill, ending Big Pharma's legal protection, and paving the way for a safer and more accountable vaccine industry.
The clock is ticking. We need as many signatures as possible to make an impression.
Complete your signature
Sign this petition now!
Support the Vaccine Indemnity Bill 2023
Dear Senators,
It is critical that we ensure the highest safety standards for vaccines.
As such, the introduction of Senator Ralph Babet's Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 is a step in the right direction.
This bill challenges the current indemnity arrangements.
It stands against the unfair protection of Big Pharmaceutical companies, who currently escape liability for adverse vaccine effects. This must change.
By removing legal indemnity, we ensure accountability and safety. Manufacturers must be incentivised to maintain the highest safety standards, reducing potential harm to consumers.
Transparency and trust will be restored. Knowing that manufacturers can be held responsible will increase public faith in vaccines.
Consumer rights will be reinforced. If harm is suffered from a product, consumers should have the right to seek compensation.
Rushed processes will be discouraged. Manufacturers will be less tempted to push products to market without thorough testing and validation.
Market competition will improve. Manufacturers will need to compete not just on efficacy, but also on safety.
Judicial scrutiny will be enhanced. Legal challenges can lead to a greater understanding of potential vaccine side effects.
Financial responsibility will be ensured. Costs associated with potential side effects should not be borne solely by individuals or the public healthcare system.
The vaccine industry will align with other sectors. Like automotive or electronics sectors, product liability should be a key business component.
Continuous monitoring and improvement will be incentivized. Manufacturers will be motivated to continually monitor, report, and improve upon their vaccine's safety.
The moral responsibility will be recognised. Those who profit from a product should also bear associated risks.
Better communication will be encouraged. Manufacturers may be more proactive in communicating potential risks, leading to better-informed vaccine recipients.
Fairness in compensation will be established. A more consistent and fair compensation system for those with genuine adverse reactions to vaccines will be implemented, as opposed to inconsistent government schemes.
I urge you to recommend that the Senate pass this critical Bill.
Let's ensure justice, transparency, and safety for all Australian vaccine consumers.
Kind regards,
Support the Vaccine Indemnity Bill 2023
Dear Senators,
It is critical that we ensure the highest safety standards for vaccines.
As such, the introduction of Senator Ralph Babet's Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 is a step in the right direction.
This bill challenges the current indemnity arrangements.
It stands against the unfair protection of Big Pharmaceutical companies, who currently escape liability for adverse vaccine effects. This must change.
By removing legal indemnity, we ensure accountability and safety. Manufacturers must be incentivised to maintain the highest safety standards, reducing potential harm to consumers.
Transparency and trust will be restored. Knowing that manufacturers can be held responsible will increase public faith in vaccines.
Consumer rights will be reinforced. If harm is suffered from a product, consumers should have the right to seek compensation.
Rushed processes will be discouraged. Manufacturers will be less tempted to push products to market without thorough testing and validation.
Market competition will improve. Manufacturers will need to compete not just on efficacy, but also on safety.
Judicial scrutiny will be enhanced. Legal challenges can lead to a greater understanding of potential vaccine side effects.
Financial responsibility will be ensured. Costs associated with potential side effects should not be borne solely by individuals or the public healthcare system.
The vaccine industry will align with other sectors. Like automotive or electronics sectors, product liability should be a key business component.
Continuous monitoring and improvement will be incentivized. Manufacturers will be motivated to continually monitor, report, and improve upon their vaccine's safety.
The moral responsibility will be recognised. Those who profit from a product should also bear associated risks.
Better communication will be encouraged. Manufacturers may be more proactive in communicating potential risks, leading to better-informed vaccine recipients.
Fairness in compensation will be established. A more consistent and fair compensation system for those with genuine adverse reactions to vaccines will be implemented, as opposed to inconsistent government schemes.
I urge you to recommend that the Senate pass this critical Bill.
Let's ensure justice, transparency, and safety for all Australian vaccine consumers.
Kind regards,
